SkinBioTherapeutics (SBTX) RNS Announcements

Add to Alert list
Date Time Source Announcement
12 Dec 2024 02:45 PM
RNS
Holding(s) in Company
04 Dec 2024 03:55 PM
RNS
Posting of Annual Report and Notice of AGM
04 Dec 2024 03:54 PM
RNS
Final Results
04 Dec 2024 07:00 AM
RNS
Notice of Results
29 Nov 2024 11:00 AM
RNS
Notice of Results
19 Nov 2024 07:00 AM
RNS
Finalisation of commercial agreement with Croda
25 Oct 2024 04:29 PM
RNS
Holding(s) in Company
23 Oct 2024 02:40 PM
RNS
Integration update and share price movement
17 Oct 2024 07:00 AM
RNS
Holding(s) in Company
16 Oct 2024 07:00 AM
RNS
Issue of Equity and Total Voting Rights
11 Oct 2024 07:00 AM
RNS
Acquisition and Financial Update
04 Oct 2024 02:02 PM
RNS
Notice of Investor Meet Company Presentation
19 Sep 2024 07:00 AM
RNS
Final testing of SkinBiotix by Croda completed
13 Aug 2024 12:49 PM
RNS
Holding(s) in Company
08 Aug 2024 07:00 AM
RNS
Holding(s) in Company
02 Aug 2024 07:00 AM
RNS
Investment of £1.56m from new investors
29 Jul 2024 07:01 AM
RNS
Appointment of Senior Croda VP as Board Advisor
29 Jul 2024 07:00 AM
RNS
Full year trading update
23 Jul 2024 07:00 AM
RNS
Closure of Convertible Bond Facility
22 Jul 2024 07:00 AM
RNS
Conversion Notice and Total Voting Rights
15 Jul 2024 07:00 AM
RNS
Notice of Business Update & Investor Presentation
28 Jun 2024 03:16 PM
RNS
Conversion Notice and Total Voting Rights
18 Jun 2024 07:00 AM
RNS
AxisBiotix Acne study reports positive data
29 May 2024 07:00 AM
RNS
Conversion Notice and Total Voting Rights
11 Apr 2024 11:44 AM
RNS
Holding(s) in Company
05 Apr 2024 07:00 AM
RNS
Conversion Notice & Total Voting Rights
22 Mar 2024 07:00 AM
RNS
Half-year Report
18 Mar 2024 11:36 AM
RNS
Holding(s) in Company
18 Mar 2024 07:00 AM
RNS
New research project and CSO to return to academia
12 Mar 2024 07:00 AM
RNS
Conversion Notice and Total Voting Rights
08 Mar 2024 09:43 AM
RNS
Notice of Results
28 Feb 2024 12:41 PM
RNS
Conversion notice and alternative financing
27 Feb 2024 07:00 AM
RNS
Positive Interim AxisBiotix Acne study results
20 Feb 2024 07:00 AM
RNS
Dermatonics to launch Once Heel Balm in AMEA
09 Feb 2024 07:00 AM
RNS
Conversion Notice and Total Voting Rights
06 Feb 2024 07:31 AM
RNS
Dermatonics Full Year trading update
26 Jan 2024 07:00 AM
RNS
Completion of Acquisition of Dermatonics
25 Jan 2024 07:00 AM
RNS
Acquisition of Dermatonics
25 Jan 2024 07:00 AM
RNS
£5.0m Convertible Bond Facility & First Drawdown
29 Dec 2023 10:49 AM
RNS
Result of AGM
29 Dec 2023 10:49 AM
RNS
Result of AGM
29 Dec 2023 08:13 AM
RNS
Update on transaction timelines to early 2024
06 Dec 2023 07:00 AM
RNS
Notice of AGM and posting of Annual Report
30 Nov 2023 05:25 PM
RNS
Final Results
30 Nov 2023 07:00 AM
RNS
AxisBiotix-Ps™ to launch on Amazon UK
24 Nov 2023 07:00 AM
RNS
Holding(s) in Company
23 Nov 2023 03:37 PM
RNS
Holding(s) in Company
22 Nov 2023 07:00 AM
RNS
Update regarding Nominated Adviser and Broker
21 Nov 2023 07:00 AM
RNS
Result of Retail Offer
17 Nov 2023 07:00 AM
RNS
Result of Placing

SkinBioTherapeutics is a life science company that develops technologies to improve health by harnessing the human microbiome.

SkinBioTherapeutics is based in Newcastle upon Tyne, United Kingdom.

SkinBioTherapeutics is listed in London under the ticker SBTX.

SBTX share price listed at 16p in 2017.

UK 100